产品名称
Kromasil® Eternity™ C18 高效液相色谱柱, 5 μm particle size, pore size 100 Å, L × I.D. 250 mm × 4.6 mm
agency
suitable for USP L1
product line
Kromasil®
manufacturer/tradename
Kromasil® ET-5-C18-4.6X250
availability
available only in USA, Canada and Puerto Rico
extent of labeling
14% Carbon loading
technique(s)
HPLC: suitable
L × I.D.
250 mm × 4.6 mm
surface area
330 m2/g
matrix active group
C18 (octadecyl) phase
particle size
5 μm
pore size
100 Å
pH range
1-12
application(s)
food and beverages
separation technique
reversed phase
正在寻找类似产品? 访问 产品对比指南
Application
- Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.: This study developed and validated an HPLC-MS/MS method for determining clopidogrel in human plasma. The Kromasil® Eternity C18 HPLC column was employed to achieve the separation. This method was shown to be efficient, precise, and suitable for pharmacokinetic studies (Liu et al., 2016).
- Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.: The study focused on developing a stability-indicating assay method for atorvastatin and ezetimibe using UPLC. The Kromasil® Eternity C18 HPLC column was critical in achieving the required resolution and sensitivity, demonstrating its role in stability studies of pharmaceutical combinations (Goel et al., 2013).
Legal Information
Eternity is a trademark of EKA Chemicals AB
Kromasil is a registered trademark of EKA Chemicals AB
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持